INTRODUCTION
The events leading to orthodontic tooth movement are complex and include interactions between the alveolar bone cells and periodontal ligament (PDL) cells, along with multiple intercellular actions. The tooth displacement and remodeling activities are a consequence of an inflammatory process induced by mechanical stimuli. The cellular, biochemical and molecular events that occur during orthodontic tooth movement have been extensively studied. During orthodontic treatment, the forces exerted on the tooth distort the PDL's extracellular matrix and alter the cellular shape and cytoskeletal configurations. These changes may modify the flow rate and composition of the gingival crevicular fluid (GCF).
1 Analysis of GCF samples may provide a better understanding of the biochemical processes associated with tooth movement. Mechanical stimulation causes an inflammatory reaction within the periodontal tissues, which in turn, may trigger the biological processes associated with bone remodeling. Force application disrupts the equilibrium that exists between bone formation and resorption, resulting in more bone resorption than formation on the pressure side and more bone formation than resorption on the tension side. With orthodontic intervention, prolonged pressure on the teeth results in enhanced remodeling of periodontal structures, including supracrestal gingival and PDL fibers, as well as the alveolar bone.
2 Orthodontic movement promotes remodeling of the alveolar bone, which is mediated by inflammatory-like reactions characterized by vascular changes and infiltration of leukocytes. 3, 4 During orthodontic movement, changes in factors, and mechanical stimulation activate osteoblasts to produce osteoprotegerin ligand, which is vital for osteoclast differentiation and activity. Osteoblasts also regulate mature osteoclasts downstream of the osteoprotegerin ligand in other ways, including through interstitial collagenase activity. 6 During bone remodeling, components of the extracellular matrix, such as collagen, are degraded and removed, and new components are synthesized and deposited. The efficiency of orthodontic treatment is attributed to the outcome of various mechanics employed for tooth movement. An understanding of the array of biological events that underlie tooth movement is essential for the clinician.
1,7
The GCF is a complex mixture of substances derived from serum, host inflammatory cells, structural cells of the periodontium, and oral bacteria. It arises from the gingival plexus of blood vessels in the gingival corium, subjacent to the epithelial lining of the dentogingival space. The GCF can be isolated from the healthy sulcus, although only in small amounts. In a healthy periodontium, GCF represents the transudate of gingival tissue interstitial fluid produced by an osmotic gradient that tends to increase in volume with inflammation and greater capillary permeability. 8 The components found in the GCF originate from the blood, host tissues, and subgingival plaque. 9 The molecules isolated from the sulcular fluid include electrolytes, small organic molecules, proteins, cytokines, specific antibodies, bacterial antigens, and enzymes of both host and bacterial origin. The GCF was initially considered to be a continuous transudate, but it is currently considered to be an inflammatory one.
10
The host-derived substances in the GCF include antibodies, cytokines, enzymes and tissue degradation products. During inflammatory conditions, such as gingivitis and periodontal disease, the inflammatory exudate increases by more than 5-fold. 11 Nearly half of the cells in the GCF are leukocytes; thus, the major route of entry of these cells into the oral cavity is through the gingival sulcus. These inflammatory cells persistently emigrate from the peripheral blood stream into the gingival sulcus due to chemotactic factors initiated by inflammation.
9
Orthodontic forces produce an environment that can be described as 'a continuous sequence of inflammation and repair designed to restore normal tissue continuity and function. 12 It has been observed that markers of bone remodeling and destruction can also be found in GCF. Therefore, it has been shown that GCF may reflect the immune and inflammatory reactions arising from both periodontitis and the application of orthodontic force.
13,14
The tooth-supporting tissues are constantly remodeled under normal conditions with physiological tooth migration. Mechanical stimuli cause an inflammatory reaction within the periodontal tissues, which in turn may trigger the biological processes associated with bone remodeling. With orthodontic intervention, prolonged pressure on the teeth results in enhanced remodeling of periodontal structures, including supracrestal gingival and PDL fibers, as well as alveolar bone.
2
The measurement of biological markers in the GCF and their association with clinical outcomes can be useful for monitoring and predicting the outcome of orthodontic treatment. The effectiveness of treatment can also be improved based on individual tissue responses. The longitudinal effect of different force delivery systems on tooth movement can be investigated by evaluating biochemical changes in the GCF. Thus, GCF analysis may provide a noninvasive method, allowing the modification of retention procedures after orthodontic treatment because of the unpredictable nature and extent of posttreatment relapse following retention. The objective of this systematic review is to critically evaluate the GCF markers related to orthodontic tooth movement reported in the literature.
METHODOLOGY

Search Strategy
The search intended to address the question 'Do variations in the GCF components reflect orthodontic tooth movement?' The focused question was developed as per the patient, intervention, comparison, and outcome (PICO) format. 15 Two investigators independently searched the medline, EMBASE, cochrane library, web of science, google scholar, and scopus databases for relevant studies. The search was carried out using a combined text and MeSH search strategy; using the keywords 'gingival crevicular fluid' and 'orthodontic' and/or 'biomarker' or 'tooth movement'. Publications in English between 2000 and 2014 that estimated GCF components as markers in the diagnosis and assessed the severity or responses to treatment were included. Due to the large number of markers used and the lack of a sufficient number of studies dealing with each marker, the accuracy and predictability of the markers were not considered in this systematic review. The markers are listed in Table 1 with relevant references.
Study Selection Criteria
Studies reporting an association between orthodontic tooth movement and alterations in the components in GCF were included. The types of studies included were: cross-sectional, experimental and interventional studies. Patients in all age groups were included. Studies presented solely in the form of abstracts in scientific conferences and studies published in languages other than English were not considered in this review.
Interleukins
Interleukins (ILs) represent one of the proinflammatory cytokines released from many cell types, such as fibroblasts, osteoclasts, and polymorphonuclear leukocytes (PMNs). The time-related production of regulatory proteins or proinflammatory cytokines, such as interleukins that are involved in the periodontal remodeling processes is provoked by orthodontic stimuli. 16 The study of interleukins as biomarkers to understand the cellular metabolic reactions involved in orthodontic tooth movement has been considered mainly due to their role in the normal physiologic turnover of bone as well as remodeling processes associated with the application of mechanical stress. [17] [18] [19] [20] The IL-1, IL-6 and IL-8 are proinflammatory
interleukins, that have been identified in the GCF during orthodontic tooth movement. 21 Interleukin-1, a cytokine with proinflammatory effect and a potent stimulator of bone resorption, is produced by activated macrophages, monocytes, B-cells, neutrophils, fibroblasts, and epithelial 87 Rody et al, 57 Grant et al, 86 Ribagin et al, 25 Luppanapornlarp et al 80 , Tzannetou et al 26 , Ren et al, 13 Iwasaki et al, 88 Basaran et al 82 Giannopoulou et al, 61 Yamaguchi et al 63 , Dudic et al, 62 Iwasaki et al, 56 Lee et al, 30 Iwasaki et al, 89 Iwasaki et al 19 
IL-2
Basaran et al 82 IL-6 van Gastel et al, 90 Ren et al, 13 Basaran et al, 82 Ren et al, 14 Grant et al 86 IL-8 van Gastel et al, 90 Grant et al, 86 Ren et al, 13 Basaran et al, 82 Tuncer et al 81 TNF-a Grant et al, 86 Karacay et al 5 , Ren et al, 13 Basaran et al 82 Anti-inflammatory mediators IL-1RA Rody et al, 57 Iwasaki et al, 88 Iwasaki et al, 56 Iwasaki et al, 89 Iwasaki 
PGE2
Dudic et al, 62 Giannopoulou et al, 61 Lee et al, 30 Ren et al Enzymes ALP Abdul Wahab et al, 51 Abdullah et al, 91 Batra et al, 92 Perinetti et al 52 
AST
Abdul Wahab et al, 51 Perinetti et al 52 
LDH
Abdul Wahab et al, 51 Perinetti et al, 76 Serra et al, 44 Alfaqeeh 49 Ingman et al, 3 Ribagin and Rashkova 25 MMP-9 Grant et al, 86 Bildt et al 83 TIMP-1, TIMP-2 Grant et al, 86 Bildt et al 83 Bone biomarkers OPG Rody et al, 57 Tuncer et al, 81 Grant et al, 86 Barbieri et al, 69 Kawasaki et al, 40 Toygar et al, 93 Nishijima et al 39 
RANKL
Rody et al, 57 Grant et al, 86 Kawasaki et al, 40 Nishijima et al, 39 Kuroki et al 94 
RANK
Barbieri et al 69 
Osteocalcin
Alfaqeeh and Anil
95
Others Substance P Giannopoulou et al, 61 Dudic et al, 62 Yamaguchi et al 63 GM-CSF Grant et al, 86 Ren et al JcDP cells. It is involved in the proinflammatory process, matrix degradation, and wound healing. 22 Interleukin-8 is produced and secreted by many cells, such as fibroblasts, epithelial cells, endothelial cells and alveolar macrophages, in response to inflammation. It is a potent proinflammatory cytokine that plays an important role in the recruitment and activation of neutrophils during inflammation. Therefore, neutrophils and other inflammatory cells migrate out of PDL capillaries to the inflammatory region. Interleukin-6 is a macrophage and T-cell originating cytokine. The healing of periodontal pockets may be affected by an accumulation of IL-6 in the adjacent connective tissue as a result of increased synthesis or reduced release into the GCF. 23 Studies have
shown that IL-1b can stimulate bone resorption during orthodontic tooth movement.
24-26
Tumor Necrosis Factor-a
Tumor necrosis factor-a (TNF-a) is a monocyte/ macrophage-derived proinflammatory cytokine that can stimulate proteolytic enzyme synthesis and osteoclast activity. It is another proinflammatory cytokine that has been investigated in orthodontic tooth movement and is involved in bone resorption and both acute and chronic inflammation. Tumor necrosis factor-a is produced primarily by activated monocytes and macrophages and by osteoblasts, epithelial cells, and endothelial cells. 27 It is also an apoptotic factor for osteocytes, which could be the signal for osteoclast recruitment to resorb bone in the side undergoing PDL pressure, while simultaneously inhibiting osteoblasts. 28 
Prostaglandin E2
Prostaglandin E2 (PGE2) is a metabolite of arachidonic acid and a potent biochemical mediator of inflammation, with many proinflammatory effects. It has been reported to act as a biochemical mediator of bone resorption induced by orthodontic tooth movement. Orthodontic force applied to the tooth stimulates the localized cells to synthesize and secrete PGE2, which, in turn, stimulates osteoclastic bone resorption. 29 Prostaglandin E2 is known to be a potent stimulator of bone resorption and its production is controlled in part by IL-1. Studies have shown that the level of PGE2 in human GCF was highest 24 hours after the mechanical force was applied and decreased to the baseline within 7 days.
24,30
Glycosaminoglycans Glycosaminoglycans (GAGs) are found in the extracellular matrix of mineralized and other connective tissues and are negatively charged complex carbohydrates that are linked covalently in the native state to a core protein to form proteoglycans. 31 The changes in GCF-GAGs during and after orthodontic treatment have been investigated. 31 The change in a GAG component, chondroitin sulfate, was related to the duration of retention, while the increase in GCF volume during orthodontic movement and the decrease during retention were related to changes in the severity of gingival inflammation. The GAGs in human GCF during orthodontic movement were also studied by Last et al. 32 They concluded that the GAG composition of GCF, particularly chondroitin sulfate, appears to reflect changes that occur in the deeper periodontal tissues of alveolar bone and PDL orthodontic treatment. Samuels et al showed varying GAG levels with different types of orthodontic tooth movement in a study of GCF during orthodontic treatment. 33 The level of chondroitin sulfate, in particular, could be a potential marker to be monitored during orthodontic tooth movement.
Granulocyte Macrophage Colony Stimulating Factor
Granulocyte macrophage colony stimulating factor (GM-CSF) and vascular endothelial growth factor (VEGF) can induce osteoclast recruitment. They are considered to be closely involved with the bone remodeling process. An increase in both VEGF and GM-CSF concentrations in the GCF during canine retraction has been reported. 34 These factors may induce bone remodeling via osteoclastic bone resorption.
Osteocalcin
Osteocalcin (OC) is a non-collagenous matrix protein and is a major component of bone extracellular matrix. 35 It is produced by osteoblasts and has been described as the most specific marker of osteoblastic function.
36
Structurally, it binds to both major bone components (collagen and apatite), and is believed to play a role in both-bone resorption and mineralization. The GCF-OC is considered a marker for bone turnover originating during bone formation as well as bone resorption. Osteocalcin has been found in the GCF from patients with periodontal disease, and increases in GCF's OC concentration have been associated with high rates of bone turnover through the enhancement of osteoclastogenesis.
37,38
Receptor Activator of Nuclear Factor Kappa-B, Osteoprotegerin and Receptor Activator of Nuclear Factor Kappa-B Ligand
Receptor activator of nuclear factor kappa-B (RANK) is known to stimulate osteoclastic generation from precursor cells. The role of RANK and its receptors, namely osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL), is very crucial in the bone remodeling process. During orthodontic tooth movement, RANKL has been implicated in the pressureinduced generation and maintenance of osteoclasts by binding to RANK. Osteoprotegerin is a decoy receptor produced from the osteoblastic lineage that prevents the maturation of osteoclasts and apoptosis with RANK for RANKL. An increase in the 'RANKL-RANK' level and a decrease in OPG level were observed 24 hours after the application of an orthodontic force, which is suggestive of bone resorption.
39,40
Transforming Growth Factor-b1
Transforming growth factor-beta1 (TGF-b1) is a multifunctional cytokine that is involved in angiogenesis, immune suppression, extracellular matrix synthesis, apoptosis and cell growth inhibition. 41 TGF-b1 is one of the key cytokines with pleiotropic properties that has both proinflammatory and anti-inflammatory features in the regulation of the inflammatory infiltrate. This cytokine is a chemoattractant for neutrophils, monocytes, mast cells and lymphocytes. It also causes the release of proinflammatory cytokines, such as IL-1, IL-6 and TNF-a by aforementioned cells. 42 
Lactate Dehydrogenase
Lactate dehydrogenase (LDH) is an enzyme that is normally limited to the cell cytoplasm and is released extracellularly, only after cell death. Studies have demonstrated a correlation between LDH activity in GCF and orthodontic tooth movement.
43-45
Matrix Metalloproteinases
Matrix metalloproteinases (MMPs) are enzymes that play a central role in PDL remodeling both in physiological and pathological conditions. During orthodontic tooth movement, the collagenous extracellular matrix of the PDL and alveolar bone is remodeled. Bone resorption by osteoclasts involves demineralization of the bone inorganic matrix by acid and degradation of the bone organic matrix by cathepsin K and MMPs, although the precise role of MMPs in osteoclastic bone resorption is not fully understood. 46, 47 Collagenase-1 (MMP-1) and collagenase-2 (MMP-8) initiate this tissue remodeling due to their unique ability to cleave native triple-helical interstitial collagen. During orthodontic force application in dogs, MMP-1 gene expression was increased, and later decreased after force removal. 48 However, the detection of MMP-1 in the GCF of patients undergoing orthodontic treatment was inconclusive. 49 
Acid and Alkaline Phosphatase
Monitoring acid and alkaline phosphatase (ALP) activity in tissues is a common way to assess bone turnover. Bone resorption induces elevations in acid phosphatase activity, whereas bone formation is associated with higher alkaline phosphatase activity. 50 Typically, alkaline phosphatase will be elevated during early tooth movement, while the increase of acid phosphatase will accompany later stages of tooth movement. 50 
Aspartate Aminotransferase
Apoptosis releases aspartate aminotransferase (AST), a soluble enzyme, to the extracellular environment from the cytoplasm of cells. Therefore, elevated AST levels after 28 days in the GCF mirror the tissue destruction and bone remodeling processes that occur in the periodontium during controlled orthodontic tooth movement.
51,52
Cathepsin B
Cathepsin B (CAB), an intracellular lysosomal cysteine proteinase, is a multifunctional biomarker that plays a key role in the initiation and continuation of inflammatory processes and is also involved in degrading extracellular components; including collagen and protein turnover in the lysosomal system. High levels of CAB in as early as 24 hours is reflective of the clinical inflammatory process during the primary stages of orthodontic treatment. 53 The subsequent increment of CAB by 1 month post-treatment is indicative of the biological activity of decomposing the exposed collagen fiber and collagen degradation by-product.
b-Glucuronidase
The lysosomal enzyme b-glucuronidase is a marker of primary granule release from neutrophils and takes part in the degradation process of connective tissue. A significant rise of b-glucuronidase after 2 weeks of orthodontic appliance activation has been observed. 55 
Interleukin-1 Receptor Antagonist
Interleukin-1 receptor antagonist (IL-1RA) is secreted by various types of immune cells and is a natural inhibitor of the proinflammatory effect of IL-1b, thereby modulating IL-1b-related immune and inflammatory responses to orthodontic forces. Interleukin-1 receptor antagonist is determined by decreased activity index (AI), which is the ratio of the concentration of IL-1b and IL-1RA in GCF.
A lower value of IL-1RA is seen as a positive correlation between decreased gingival IL-1RA expression and faster orthodontic tooth movement.
56,57
JcDP
Interferon γ
Produced predominantly by T-cells, increased levels of interferon γ (IFN-γ) play an important role in paradental remodeling. Periodontium remodeling during orthodontic tooth movement can be attributed to its immunoregulatory role and bone modeling through nitric oxide (NO) bone cell-activation, which is a potent stimulator of osteoclasts through its activation of RANKL and consequent induction of bone resorption.
1,58
Leptin
Classified as a cytokine, leptin is a polypeptide hormone that plays a significant role in increased phagocytosis by macrophages in response to initial stress/strain created by orthodontic forces. This is followed by decreased levels of leptin in the GCF as a consequence of tissue resorption and likely cell necrosis in the PDL during orthodontic treatment.
59
Insulin-like Growth Factor-1 and Insulin-like Growth Factor-Binding Protein 3
Insulin-like growth factor-binding protein 3 (IGFBP-3) binds with insulin-like growth factor-1 (IGF-1). The IGF-1/ IGFBP-3 complex plays an important role in alveolar bone remodeling due to orthodontic forces. Decreased levels of IGFBP-3 secretion into GCF and altered molecular structures are observed due to orthodontic forces. However, these changes in IGFBP-3 show no association with the binding of IGF-I, indicative of an IGF-independent role of this binding protein in tooth movement.
60
Substance-P Substance-P is a neuropeptide that participates in the initial phase of orthodontic treatment by delivering and accumulating leukocytes to express a local immune response at the site of orthodontic forces. It is also involved in stimulating the bone resorption activity of osteoclasts and modulating the emotional stress experienced by the pain from the inserted appliance. Studies revealed a peak in production in the experimental sites one day after the insertion of the orthodontic appliance.
61-63
Pentraxin-3
Pentraxin-3 (PTX3) is an acute-phase protein that is involved in the modulation of the aseptic inflammatory reaction. Therefore, during initial orthodontic treatment, its level rapidly increases and reaches its peak by 24 hours, after which it self-decreases. Thus, it can be a potential early biomarker in orthodontic tooth movement.
64
DISCUSSION
Orthodontic forces trigger inflammatory process in the involved dental and periodontal tissues. Lymphocytes, monocytes and macrophages invade these tissues, enhancing the synthesis and release of various neurotransmitters, cytokines, growth factors, and metabolites of arachidonic acid, thus leading to increased osteoclastic activity. 65 In orthodontics, the inflammatory process is a natural bridge toward solving functional and/or esthetic problems, as no tooth movement can be achieved without inflammation. However, orthodontically-induced inflammation and inflammatory mediators are transitory. Movement of teeth induced by orthodontic treatment involves reactions in the alveolar bone and in the PDL, gingiva, blood vessels and nerves. 1 The bone remodeling that occurs during orthodontic tooth movement has been classically described as a continual and balanced process, characterized by bone deposition at sites of tension and bone resorption on the pressure side. Moreover, histomorphometric data have suggested that in both tension and compression sites, there may be an initial asynchronous phase in which bone resorption is greater than bone deposition. To date, few studies have focused on the GCF constituents involved in bone remodeling during orthodontic tooth movement. The bone tissue reactions in response to orthodontic treatment are still elusive, and a detailed understanding of the biology of tooth movement and the outcome of treatment in individual patients is a complex process. The development of molecular biology along with translational studies in humans as well as in experimental systems are likely to provide much more detailed insight into the cellular and molecular mechanisms involved in the modeling processes induced by orthodontic forces. When bone is mechanically stimulated, the osteoclasts and their precursors are immediately activated to initiate resorption. 66 Furthermore, osteoclast differentiation and recruitment are stimulated by hormones, cytokines, growth factors, and matrix components partly produced by osteoblasts.
67
The biological response to orthodontic forces can be monitored by the analysis of various cell mediators and enzymes found in GCF. The induction of these markers comes from the compression of the PDL after the application of orthodontic force in levels sufficient enough to be diffused into the GCF. A number of GCF constituents have been studied in relation to the events that take place during orthodontic tooth movement. 16, 68 Markers, such as OC, TGF-b, ALP, TNFa, CAB, epidermal growth factor, beta-2-microglobulin, glycosaminoglycans components, PGE2 as well as LDH activity and AST activity have been found to be significantly elevated in the GCF surrounding teeth undergoing orthodontic movement. 5, 30, 33, 45, 50, 54, [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] The levels of interleukins in the GCF, especially those of IL-1b, IL-8, IL-2 and IL-6 have been shown to increase during orthodontic treatment. 72, [79] [80] [81] [82] The GCF level of MMPs and their inhibitors has been generally shown to peak at an average of 1 to 2 days after the application of the stimulus and return to baseline values after approximately 1 week. [83] [84] [85] The role of RANKL and its inhibitor OPG in inducing alveolar bone remodeling during orthodontic tooth movement has been demonstrated. 39, 40, 86 Based on the observations of various studies, it can be concluded that the analysis of GCF mediators reflects the biological activity that occurs in the periodontium during orthodontic tooth movement. However, due to the heterogeneity of the available studies, probably related to different GCF sampling and analysis procedures, it is difficult to draw a concrete conclusion. Thus, it is suggested that future studies should focus on the refinement of GCF sampling and measuring protocols, and the relationship between mediator production and force reactivation in order to provide a better illustration of the high potential of GCF as a diagnostic tool to monitor clinical outcome in orthodontics.
CONCLUSION
Studies have used GCF to assess changes within the periodontium and have related those changes to tooth movement. However, the majority of these studies have assessed individual biomarkers, which are representative of only a single biological pathway. Therefore, the assessment of a group of GCF biomarkers may provide better insight, and future research is encouraged to move in that direction.
